Australia gives recognition to India’s Covaxin
Australia’s Therapeutic Goods Administration (TGA) has determined that India’s Covid-19 vaccine, Covaxin, manufactured by Bharat Biotech and BBIBP-CorV, manufactured by Sinopharm, China vaccines would be recognised for the purpose of establishing a traveller’s vaccination status.
This recognition is for travellers aged 12 and over who have been vaccinated with Covaxin, and those 18 to 60 who have been vaccinated with BBIBP-CorV.